CRELUX, a WuXi AppTec Company
Anna Raba is a Scientist with a background in Translational Medicine and Tumor Biology. Anna has worked in various research positions in companies such as CRELUX, Boehringer Ingelheim, and Merck KGaA, as well as completing internships at institutions like Stockholm University and Ontario Cancer Institute. Anna's expertise lies in targeting nucleotide metabolism to improve anti-cancer therapy.
This person is not in the org chart
CRELUX, a WuXi AppTec Company
CRELUX, part of WuXi AppTec’s Research Service Division, is a global provider of structure based drug discovery solutions. We have been delivering customized and integrated services in drug discovery, X-ray crystallography, protein supply, biophysical analysis and fragment screening, to support small and large molecule, as well as biopharmaceutical drug discovery, for more than a decade. Our mission is to enable our clients to perform their work faster, more efficiently and more successfully. Integrating the comprehensive portfolio of services offered by our parent company WuXi AppTec, CRELUX offers a unique opportunity for our collaborators to accelerate discovery activities. Imprint: CRELUX GmbH Am KIopferspitz 19a 82152 Martinsried Germany www.crelux.com crelux_info@wuxiapptec.com phone: +49 89 7007600 VAT: DE242220245 Amtsgericht München HRB 165552 Managing Director: Dr. Gundel Hager